PHOENIX, AZ- Dr. George Dangas, Professor of Medicine (Cardiology and Surgery) at the Icahn School of Medicine of Mount Sinai in New York City, assumed the office of the President of the Society for Cardiovascular Angiography & Interventions (SCAI) during the closing ceremonies at the SCAI 2023 Scientific Sessions held May 18-20 in Phoenix, AZ.
The Director of Cardiovascular Innovation at the Zena and Michael A. Wiener Cardiovascular Institute at Icahn Mount Sinai and Chief of Cardiology at Mount Sinai Queens is the first Mount Sinai cardiologist to hold this position and will serve as the 46th President of SCAI [2023-2024].
In this new role, Dr. Dangas will fulfill a number of important responsibilities including acting as the spokesperson for SCAI, supporting its development efforts, and helping manage its operations.
A leading authority in the performance of nonsurgical cardiovascular and valve interventions using both established and novel techniques, and in preventing and dissolving endovascular thrombosis, Dr. Dangas has served as a key faculty and program committee member for various SCAI meetings and events and is a former SCAI Trustee.
“I am deeply honored to serve as SCAI president this year”, he said, adding that “our society is moving the interventional cardiology specialty forward in such impactful ways that are reflective of our current times and speak to the innovation required to advance patient care. I am excited to collaborate with our physician and associate members to address the needs of our profession and make an imprint on global health”.
Dr. Dangas completed medical and postgraduate studies at the National and Capodistrian University of Athens [Greece] and his internship and residency in internal medicine at Miriam Hospital and Brown University in Providence, Rhode Island. He completed his cardiovascular disease and interventional cardiology fellowships at The Mount Sinai Hospital, New York City and has been certified by the American Board of Internal Medicine in Cardiovascular Disease and Interventional Cardiology, and also elected Master of the American College of Cardiology.
Founded in 1978, SCAI’s mission is to lead the global interventional cardiovascular community through education, advocacy, research, and quality patient care.
SCAI has dedicated its work to advancing the profession and is the designated society [of more than 4,500 members from 100 different countries] for guidance, representation, professional recognition, education, and research opportunities for invasive and interventional cardiology professionals.
More information is available online: https://scai.org/.
